Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 1–50 of 111 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05272293	Immunotherapy With ex Vivo Expanded Haploidentical Natural Killer Cells for Children/Young Adults With AML	unknown	Phase 1 / Phase 2	15	Belarusian Research Center for Pediatric Oncology, Hematology and ImmunologyOTHER	1	Aug 28, 2024	clinicaltrials
NCT05334693	Expanded Haploidentical Natural Killer Cells as Consolidation Strategy for Children/Young Adults With AML	unknown	Phase 1 / Phase 2	15	Belarusian Research Center for Pediatric Oncology, Hematology and Immunology